Partnership Applications Now Open Washington, DC – March 7, 2022 – Global Liver Institute (GLI) will convene the fifth International NASH Day (#NASHday) on June 9, 2022 with the theme Stop NASH...
GLI’s Liver Action Network Supports World Obesity Day to Acknowledge Strong Connection Between NASH and Obesity As members of Global Liver Institute’s Liver Action Network (LAN), the undersigned...
(Washington, D.C., March 2, 2022) – Global Liver Institute (GLI) proudly announces the expansion of the Liver Action Network (LAN) to include a partnership with Empire Liver...
(Washington, DC, Wednesday, February 16, 2022)—Today, Global Liver Institute (GLI) applauds the confirmation of the new Food and Drug Administration (FDA) Commissioner Dr. Robert Califf. On Tuesday,...
Transforming the Public Consciousness with Conversations for and about the Rare Liver Disease Community WASHINGTON, DC, FEBRUARY 1, 2022 – Global Liver Institute (GLI), a patient-led...
POLICY PERSPECTIVE Rapid advancements to policy and committees welcomed in the new year. One of the most highlighted actions was the advancement of the nomination of Dr. Robert Califf as the...
Fatty liver disease (FLD) and nonalcoholic steatohepatitis (NASH) are increasing in prevalence worldwide, creating a major global public health crisis. To adequately educate patients, practitioners,...
As we enter a third calendar year marked by COVID-19, the Omicron variant has caused pandemic peaks in cases and hospitalizations. However, we also have a greater understanding of the disease–and...
Washington, DC, January 14, 2022 – In 2021, the Global Liver Institute (GLI) formed the Liver Action Network (LAN) to better synchronize engagement across the liver advocacy...
WASHINGTON, DC and DENVER, JANUARY 6, 2021 – The Global Liver Institute (GLI), the only patient-led liver health nonprofit operating internationally, in partnership with TriSalus Life...
Recent News
Terri’s StoryWhen my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective...
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver HealthHepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you're likely familiar with the chronic health challenges...
Congress goes into recess in October while staff work behind the scenes to prepare for a potentially busy November lame-duck session Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the...
Cancer Care for the Underrepresented #Octoberis4Livers Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers...
Emerging Evidence in Liver Health: GLP-1, Pollution, and MoreDespite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies. Recent studies show promising interventions for early diagnosis and treatment, while also...
